Versant Capital Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,650
Closed -$14.4K – 2828
2026
Q2
$14.4K Buy
+2,650
New +$10.2K ﹤0.01% 2096
2026
Q1
– Sell
-1,728
Closed -$6.91K – 2808
2025
Q4
$6.91K Buy
1,728
+241
+16% +$1.34K ﹤0.01% 2132
2025
Q3
$12.6K Buy
1,487
+1,427
+2,378% +$13.8K ﹤0.01% 1834
2025
Q2
$676 Sell
60
-741
-93% -$6.81K ﹤0.01% 2528
2025
Q1
$7.58K Sell
801
-36
-4% -$364 ﹤0.01% 1861
2024
Q4
$9.42K Buy
837
+787
+1,574% +$13.8K ﹤0.01% 1432
2024
Q3
$1.41K Hold
50
– – ﹤0.01% 1661
2024
Q2
$956 Hold
50
– – ﹤0.01% 1682
2024
Q1
$1.64K Hold
50
– – ﹤0.01% 1416
2023
Q4
$1.65K Hold
50
– – ﹤0.01% 1361
2023
Q3
$1.36K Hold
50
– – ﹤0.01% 1438
2023
Q2
$1.52K Hold
50
– – ﹤0.01% 1470
2023
Q1
$1.62K Hold
50
– – ﹤0.01% 1324
2022
Q4
$1.4K Hold
50
– – ﹤0.01% 1229
2022
Q3
$2K Hold
50
– – ﹤0.01% 1067
2022
Q2
$2K Hold
50
– – ﹤0.01% 1085
2022
Q1
$2K Hold
50
– – ﹤0.01% 1124
2021
Q4
$1K Hold
50
– – ﹤0.01% 1255
2021
Q3
$2K Hold
50
– – ﹤0.01% 1116
2021
Q2
$1K Hold
50
– – ﹤0.01% 1268
2021
Q1
$1K Hold
50
– – ﹤0.01% 1350
2020
Q4
$0 Hold
50
– – ﹤0.01% 1397
2020
Q3
$0 Hold
50
– – ﹤0.01% 1359
2020
Q2
$0 Buy
+50
New +$335 ﹤0.01% 1368
2020
Q1
– Sell
-40
Closed – – 1408
2019
Q4
$0 Hold
40
– – ﹤0.01% 1416
2019
Q3
$0 Buy
+40
New +$287 ﹤0.01% 1424
2019
Q2
– Sell
-15
Closed – – 1486
2019
Q1
$0 Buy
+15
New +$237 ﹤0.01% 1603

Other funds holding EVH

Versant Capital Management's EVH Position: Q3 2026 in Review

Versant Capital Management sold out of Evolent Health (EVH) in Q3 2026, closing a stake of 2,650 shares — an estimated $14.4K sold.

Versant Capital Management first reported a position in EVH in Q1 2019 and held it in 27 quarters. The position peaked at $14.4K in Q2 2026. 193 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Versant Capital Management reported no remaining Evolent Health position as of Q3 2026 after selling out during the quarter.
  • Versant Capital Management sold 2,650 Evolent Health shares in Q3 2026, an estimated $14.4K.
  • Versant Capital Management first reported a position in Evolent Health in Q1 2019 and held it in 27 quarters.
  • Versant Capital Management's Evolent Health position peaked at $14.4K in Q2 2026.
  • 193 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.